Qube Research & Technologies (QRT)
CBIO

Qube Research & Technologies (QRT)’s Crescent Biopharma CBIO Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11
Closed -$310 – 3614
2024
Q2 		$310 Sell
11
-2,192
-100% -$228K ﹤0.01% 3355
2024
Q1 		$661K Buy
2,203
+2,154
+4,396% +$643K ﹤0.01% 2386
2023
Q4 		$11.5K Buy
49
+45
+1,125% +$7K ﹤0.01% 3586
2023
Q3 		$599 Buy
+4
New +$631 ﹤0.01% 3665
2021
Q3 		– Sell
-145
Closed -$34K – 2413
2021
Q2 		$34K Buy
+145
New +$36.9K ﹤0.01% 2054

Other funds holding CBIO

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CBIO Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Crescent Biopharma (CBIO) in Q3 2024, closing a stake of 11 shares — an estimated $310 sold.

Qube Research & Technologies (QRT) first reported a position in CBIO in Q2 2021 and held it in 5 quarters. The position peaked at $661K in Q1 2024. 36 funds tracked by Wall St. Rank hold CBIO as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Crescent Biopharma position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 11 Crescent Biopharma shares in Q3 2024, an estimated $310.
  • Qube Research & Technologies (QRT) first reported a position in Crescent Biopharma in Q2 2021 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s Crescent Biopharma position peaked at $661K in Q1 2024.
  • 36 funds tracked by Wall St. Rank held Crescent Biopharma as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.